DOSAGE & ADMINISTRATION SECTION
Dosage:
Adult:10-15 drops in half cup of water three times a day
Children: half of the same
Dosage:
Adult:10-15 drops in half cup of water three times a day
Children: half of the same
acid phos, cephalandra ind, gynmema syl, momordica charantia, syz jambol
ALCOHOL
Help support to relieve the symptoms of diabetes mellitus, for detail page please read the enclosed package (product information leaflet).
Help support to relieve the symptoms of diabetes mellitus, for detail page please read the enclosed package (product information leaflet).
Care & contra-indications:
This is a homoeopathic remedy, no contra-indications are established.
Precautions/storage:
Keep away from children and store at cool and dry place.
Precautions/storage:
Keep away from children and store at cool and dry place.
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85816-6014-1 | SYZ CEPHALANDRA | 30 mL in 1 BOTTLE, GLASS | LIQUID | 30 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 85816-6014 | 85816-6014-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALCOHOL | 3K9958V90M | IACT |
| MOMORDICA CHARANTIA FRUIT | UA63Y8U89U | ACTIB |
| COCCINIA GRANDIS WHOLE | S4R7X48WED | ACTIB |
| PHOSPHORIC ACID | E4GA8884NN | ACTIB |
| GYMNEMA SYLVESTRE ROOT | C4PVO0UUEQ | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SYZ CEPHALANDRA | ACID PHOS, CEPHALANDRA IND, GYNMEMA SYL, MOMORDICA CHARANTIA, SYZ JAMBOL | BM Private Limited | 3b3a3776-96c0-f876-e063-6394a90aaec8 | 2025-07-31 | Warnings | 85816-6014-1 85816-6014 85816601401 3b3a3776-96c1-f876-e063-6394a90aaec8 3b3a3776-96c0-f876-e063-6394a90aaec8 |
Adverse event summaries are temporarily unavailable. Other product information remains available.